Hydrochloric Acid → n-Benzoyl-l-valine-(s)-1-(p-tolyl)ethylamide

(S)-3-Benzoyl-4-isopropyl-2,5-oxazolidinedione (N-benzoyl-L-valine-NCA) (100 mg, 0.40 mmol) was dissolved in ethyl acetate (2.0 mL), followed by the addition of a solution of (S)-1-(p-tolyl)ethylamine (55 mg, 0.40 mmol) and N-methylmorpholine (61 mg, 0.60 mmol) in ethyl acetate (2.0 mL) at 0° C. The resulting mixture was stirred for 30 minutes. The reaction mixture was poured into 1 N hydrochloric acid (10 mL), followed by extraction with ethyl acetate (10 mL). The organic layer was washed successively with a saturated aqueous solution of sodium hydrogencarbonate (10 mL) and a saturated aqueous solution of sodium chloride (10 mL), and was then dried over anhydrous magnesium sulfate. The organic layer was concentrated under reduced pressure to afford the title compound (134 mg, 98%) as white crystals.

1. extractionfollowed by extraction with ethyl acetate (10 mL)
2. washThe organic layer was washed successively with a saturated aqueous solution of sodium hydrogencarbonate (10 mL)
3. dry with materiala saturated aqueous solution of sodium chloride (10 mL), and was then dried over anhydrous magnesium sulfate
4. concentrationThe organic layer was concentrated under reduced pressure

ORD record

ord-3b67c8f3bb3b4178be65a759c89eb9ce

Source dataset

uspto-grants-2003_12

DOI

10.6084/m9.figshare.5104873.v1

Patent number

US06670447B2